Jinfiniti Vitality NAD+ Booster Review 2026: Multi-Ingredient Formula, NAD Testing, and the $118 Question

What Is in the Formula

Vitality NAD+ Booster contains four ingredients: an NMN precursor, creatine monohydrate, D-ribose, and niacinamide (vitamin B3). The powder form contains 60 grams per jar with a recommended daily serving of 2,000 mg. The exact amount of NMN per serving is not broken out on the label we reviewed; the marketing material references 900 mg of "NMN + Niacinamide" in the lozenge form.

Formula details from jinfiniti.com, accessed mid-October 2026. The product page says "Other Ingredients: None," which is a clean-label claim. The four actives are the entire formula.

The rationale is multi-pathway NAD+ production. NMN converts to NAD+ through a one-step enzymatic pathway. Niacinamide feeds the salvage pathway, a different route cells use to recycle NAD+. Creatine and D-ribose support ATP production, the energy currency that works alongside NAD+ in mitochondria. The idea is that hitting multiple pathways at once raises NAD+ more reliably than NMN alone.

That idea is logical. It also raises a question: if four ingredients are better than one, why has no independent trial tested this specific combination against NMN alone? Jinfiniti cites an internal study with 26 volunteers. That study used intracellular NAD+ testing, Jinfiniti's own proprietary test, as the outcome measure. It has not been published in a peer-reviewed journal, which means no independent researchers have reviewed the methods, controls, or statistical analysis.

The Founder's Credentials: Genuine and Relevant

Dr. Jin-Xiong She is a Professor Emeritus at the Center for Biotechnology and Genomic Medicine at Augusta University, a Georgia Research Alliance Eminent Scholar, and has published over 400 papers across genomics, autoimmune disease, and chronic disease prevention. These are verifiable, substantial academic credentials.

This matters because most supplement founders have business or marketing backgrounds, not research careers. She's publication record is in PubMed, searchable, and spans decades. He established the Center for Biotechnology and Genomic Medicine at what was then the Medical College of Georgia. His transition from academic genomics to supplement entrepreneurship is a career pivot, not a credentials fabrication.

The question is whether a distinguished research career in genomics translates into a better supplement. The NMN in Jinfiniti's product undergoes the same biochemistry as NMN from any other supplier. Creatine is creatine. The difference, if there is one, would come from the formulation logic and the testing infrastructure, not from the raw ingredients being fundamentally different.

Where She's credentials add undeniable value is in the intracellular NAD+ test. Developing a validated biomarker assay requires the kind of expertise She's lab has built over decades. If the test accurately measures intracellular NAD+, a harder measurement than blood NAD+, that is a genuinely differentiated product. Whether it is worth $198 per test depends on what you plan to do with the number.

The "85% Reach Optimal" Claim: What We Know and Do Not Know

Jinfiniti says 85% of people who take the Vitality NAD+ Booster at 2,000 mg daily reach "optimal" NAD+ levels within four weeks, based on testing 26 volunteers aged 35 to 65. This claim has not been independently verified. The study used Jinfiniti's own test, Jinfiniti's own supplement, Jinfiniti's own definition of "optimal," and Jinfiniti's own analysis.

Twenty-six people. No placebo. No blinding. No peer review. A pilot, not a clinical trial. It lacks a placebo group, blinding, and peer review. That does not mean the result is wrong. It means the evidence has not been subjected to the scrutiny that would allow independent scientists to assess its reliability.

For comparison, published NMN trials that appear in PubMed typically enroll 25 to 80 participants, include a placebo group, run for 8 to 12 weeks, and report results in journals that peer-review the methodology. A 12-week study of 250 mg NMN in 30 healthy adults found NAD+ increased and the treatment was well tolerated (Okabe et al., 2022). A 60-day study tested 300, 600, and 900 mg and found dose-dependent NAD+ increases (Yi et al., 2023). These are the kinds of studies that support NMN as an ingredient. Jinfiniti's specific formula has not passed through that process.

The "optimal" threshold is also defined by Jinfiniti. The company's own NAD level chart classifies intracellular NAD+ into ranges with corresponding recommendations. When the company sets the target and measures the results with its own instrument, the 85% success rate should be read as a marketing claim until independently confirmed.

Price: The Premium and What It Buys

Vitality NAD+ Booster powder costs $118 for one jar (about 30 days at 2,000 mg/day). The subscription price is $98 per jar. NAD testing packages range from $257 to $708. By every measure, Jinfiniti is the most expensive NMN-containing option in the market.

Product	Monthly cost (at recommended dose)	What you get
Jinfiniti Vitality NAD+ Booster	$118 (one-time) / $98 (subscription)	NMN + creatine + D-ribose + niacinamide
Omre NMN + Resveratrol	$69	500 mg NMN + 500 mg resveratrol + BioPerine
ProHealth NMN Pro 500	about $45	500 mg NMN
YourHealthier NMN (our product)	about $50	500 mg NMN
Nutricost NMN	about $17	500 mg NMN

Jinfiniti costs two to seven times more per month than the alternatives. The company would argue that the multi-ingredient formula and the testing ecosystem justify the premium. That argument has merit if the formula genuinely raises NAD+ more than NMN alone and if testing gives you actionable data you would not otherwise have.

On the formula side: creatine monohydrate, D-ribose, and niacinamide are all available as standalone supplements for a few dollars each per month. You could buy 500 mg of NMN ($17 to $50/month), a jar of creatine ($10 to $15/month), D-ribose ($10/month), and a bottle of niacinamide ($5/month) and replicate the ingredient profile for $42 to $80 total, roughly half to two-thirds of Jinfiniti's price. The difference is convenience and the specific ratios Jinfiniti chose.

On the testing side: the intracellular NAD test at $198 is a real data point that no other NMN brand offers. If knowing your intracellular NAD+ level changes what you do, whether adjusting dose, switching products, or deciding to stop, the test has value. If you would take the same supplement regardless of the number, the test is an expensive confirmation.

Each Ingredient: What the Published Evidence Says

NMN, creatine, D-ribose, and niacinamide each have their own published evidence base. NMN raises blood NAD+ in human trials. Creatine is one of the most studied supplements in sports science. D-ribose supports ATP synthesis. Niacinamide is a well-established NAD+ precursor. None of them have been tested together in a peer-reviewed study.

NMN: Multiple human trials at 250 to 1,250 mg show NAD+ increases and good tolerability (Yoshino et al., 2021; Fukamizu et al., 2022). A 2026 meta-analysis found oral NMN well tolerated overall (Yang et al., 2026).

Creatine monohydrate: Extensively studied for muscle performance and cognitive function. The International Society of Sports Nutrition position stand on creatine found consistent benefits for high-intensity exercise performance and lean mass in combination with resistance training (Kreider et al., 2017). Its role in NAD+ metabolism specifically is less studied than its role in ATP cycling.

Niacinamide (nicotinamide): A form of vitamin B3 that feeds the NAD+ salvage pathway. A 2026 head-to-head trial found that NMN and NR raised blood NAD+ comparably, while plain nicotinamide (the same as niacinamide) did not (Christen et al., 2026). This is an important finding for Jinfiniti's formula: if niacinamide alone does not raise blood NAD+, its contribution to the multi-pathway formula may be less than the marketing suggests.

D-ribose: A sugar that participates in ATP synthesis. Studies in patients with heart failure and fibromyalgia have tested D-ribose supplementation with mixed results. Its connection to NAD+ production is indirect: it supports the energy currency that NAD+ helps produce, rather than feeding NAD+ synthesis directly.

The multi-pathway concept is intellectually coherent. What it lacks is the specific evidence that these four together, at these ratios, produce a larger NAD+ increase than NMN alone at the same dose. Our NMN dosage guide covers dose-response data from published trials.

How Jinfiniti Markets Its Products: The Content Ecosystem

Jinfiniti publishes "best NMN" and "best NAD" articles on its own blog that rank its Vitality NAD+ Booster as the #1 pick. Like Omre, these are brand-published rankings, not independent editorial. Jinfiniti's blog also features extensive NAD education content written around Dr. She's expertise.

Search for "best NMN supplement" or "best NAD supplement" and you will likely encounter Jinfiniti blog posts. These articles follow a familiar supplement-industry pattern: the brand's product earns the top spot, competitors are listed below with measured praise, and the conclusion directs readers to the brand's shop page.

What distinguishes Jinfiniti's content from typical supplement marketing is the scientific depth. Blog posts reference specific studies, discuss NAD+ biochemistry in reasonable detail, and carry Dr. She's name. That gives the content more substance than most competitor-comparison blogs, even though the editorial conclusion is predetermined. Our Omre review discusses the same dynamic in that brand's content strategy.

Jinfiniti also operates a partner program for healthcare practitioners, offering the intracellular NAD+ test as a clinical tool. This positions the brand in the functional medicine space alongside companies like Genova Diagnostics and Great Plains Laboratory, which sell biomarker tests through practitioners. The clinical channel adds legitimacy but also creates a B2B revenue stream that incentivizes recommending the test and the paired supplement.

NMN vs Jinfiniti's Multi-Ingredient Formula: The Practical Decision

The choice between Jinfiniti and a single-ingredient NMN product comes down to one question: do you believe the combination of NMN with creatine, D-ribose, and niacinamide produces meaningfully better NAD+ outcomes than NMN alone? Without peer-reviewed evidence for the combination, the answer is a bet, not a fact.

A buyer who wants to hedge that bet has a cheap alternative: buy NMN from any reputable brand ($17 to $50/month) and add creatine monohydrate separately ($10/month). Creatine has its own deep evidence base for muscle performance (Kreider et al., 2017) and emerging evidence for cognition, with a 2023 meta-analysis finding memory benefits in healthy adults (Prokopidis et al., 2023). D-ribose and niacinamide are inexpensive standalone supplements. The total cost of the four ingredients purchased separately is roughly half of Jinfiniti's price.

What you lose by doing that is the specific ratios, the convenience of one jar, and the testing integration. What you gain is flexibility to adjust each ingredient independently, which is arguably more "precision" than a fixed four-ingredient blend.

A 2026 review of 113 NAD-related studies found clear biological activity from NAD+ precursors but described the evidence for anti-aging outcomes as inconclusive (Gallagher et al., 2026). That conclusion applies to NMN at any dose from any brand, Jinfiniti's included. The premium price does not buy premium evidence for the desired outcomes.

Safety Considerations for the Four-Ingredient Formula

Each ingredient in Jinfiniti's formula has its own safety profile. NMN has been tested up to 1,250 mg daily for four weeks with no significant adverse events. Creatine is one of the most studied supplements and is well tolerated at standard doses. Niacinamide at high doses can cause flushing but is generally safe. D-ribose is well tolerated in most people.

The NMN safety data is covered extensively in our other NMN reviews. The key references are Fukamizu et al. for high-dose safety (Fukamizu et al., 2022) and Yang et al. for the meta-analysis (Yang et al., 2026).

The four-ingredient combination has not been separately safety-tested in a published trial, which means potential interactions between the ingredients at Jinfiniti's specific ratios are untested. Even so, all four are commonly available dietary supplements, and serious interactions between them are unlikely based on their known pharmacology.

NMN is lawful as a US dietary supplement since September 2025. Our NMN FDA status page covers the timeline. Our NMN side effects guide lists reported effects from published trials.

The Test-Act-Optimize Model: Precision Medicine or Premium Upsell?

Jinfiniti's business model is test-supplement-retest: buy the intracellular NAD+ test ($198), take the supplement, retest to verify your levels rose. This is a genuine personalization step that no other NMN brand offers. It is also a revenue structure that bundles recurring testing with recurring supplement purchases.

The concept has real appeal. Most NMN buyers take the supplement without any way to know if their NAD+ levels actually changed. Jinfiniti provides a measurement. If the test is accurate, and the founder's expertise in bioassay development lends credibility to that claim, the data is useful.

The question is what you do with the data. If your NAD+ level is "optimal" after four weeks, do you keep taking the same dose, reduce it, or stop? Jinfiniti's model encourages continued supplementation and periodic retesting. That is reasonable clinical practice if each test reveals something actionable. It is an expensive subscription if every test returns the same result and the recommendation is always "keep buying."

The starter bundle ($257) includes one NAD test and one jar of Vitality. The NAD Maintenance Package ($708) includes six jars and a test. These are meaningful expenditures, especially compared to a $17 bottle of Nutricost NMN that a buyer takes without testing and decides based on how they feel.

Neither approach is wrong. One is data-driven and expensive. The other is empirical and cheap. The question is how much certainty you need and how much you are willing to pay for it.

Jinfiniti Powder vs Lozenge: Which Format

Jinfiniti offers the Vitality formula in both powder and sublingual lozenge form at the same price ($118). The lozenge claims to increase NAD+ by 150% versus 116% for the powder. Both claims come from internal data, not published trials.

The lozenge dissolves under the tongue, allowing the active ingredients to absorb through the oral mucosa rather than passing through the digestive system. A 2026 crossover study found that sublingual NMN produced the same blood NAD+ as swallowed NMN over one hour (Wakabayashi et al., 2026). That study tested NMN alone, not a four-ingredient combination, so the result does not directly apply to Jinfiniti's lozenge. But it does suggest that the sublingual route may not inherently improve NAD+ outcomes for NMN.

The 150% vs 116% difference cited by Jinfiniti implies the lozenge is about 30% more effective than the powder. If the internal study behind those numbers was well-controlled, that is a meaningful difference. Without seeing the data, methods, or participant characteristics, we cannot assess whether the difference is real or an artifact of small sample sizes and high variability. Both numbers should be treated as preliminary until independently confirmed.

For buyers choosing between formats: the powder allows precise dose adjustment with a scale, while the lozenge offers convenience and a fixed serving. Both cost the same. If Jinfiniti's internal data is accurate, the lozenge produces a larger effect. If you value published evidence over internal claims, the difference is unverifiable and the choice comes down to personal preference.

Comparison Table: Jinfiniti vs Single-Ingredient NMN

This table puts Jinfiniti's multi-ingredient approach side by side with single-ingredient NMN on the factors that matter most for a purchase decision.

Factor	Jinfiniti Vitality NAD+ Booster	Typical 500 mg NMN capsule
Active ingredients	NMN + creatine + D-ribose + niacinamide	NMN only
Monthly cost	$98–$118	$17–$69
Published peer-reviewed trial of exact formula	No	Yes (multiple trials at 250–1,250 mg NMN alone)
NAD testing integration	Yes ($198 per test)	No
Founder credentials	PhD, 400+ papers, Georgia Research Alliance Scholar	Varies by brand
Pathway approach	Multi-pathway (salvage + de novo + ATP support)	Single pathway (NMN → NAD+)

The table makes the trade-off clear. Jinfiniti offers a broader formula, a testing ecosystem, and serious founder credentials. Single-ingredient NMN offers published evidence for the exact product you are taking, lower cost, and simpler decision-making. Neither is objectively better for everyone.

Who Jinfiniti Vitality NAD+ Booster Fits

Jinfiniti fits the buyer who wants a scientist-led, multi-ingredient NAD+ formula with a testing component and can afford the premium. It does not fit the price-sensitive buyer or someone who wants a single-ingredient NMN product aligned with published trial protocols.

The data-driven biohacker. If you want numbers, not feelings, and can afford $198 per test plus $98 to $118 per month for the supplement, Jinfiniti is the only NMN brand that will show you an intracellular NAD+ level. That is a genuine differentiator.

The multi-ingredient believer. If you already take NMN, creatine, and niacinamide separately and want them in one product, Jinfiniti consolidates three or four bottles into one jar. Whether the specific ratios add value beyond what you would get from separate products is an open question.

The budget-conscious buyer. At $118 per month, Jinfiniti costs more than most people spend on all supplements combined. If you want NMN at the same 500 mg dose tested in trials, Nutricost ($17/month), our own product ($50/month), or ProHealth ($45/month) deliver it for a fraction of the price.

The trial-evidence purist. If you want to take only what has been tested in peer-reviewed human trials at the exact doses and formulations studied, a single-ingredient NMN capsule at 250 to 500 mg matches the data more closely than any multi-ingredient formula.

Our Verdict on Jinfiniti

The founder is genuine. The test is interesting. The price is hard to justify on current evidence.

Dr. She's credentials are real, and the intracellular NAD test addresses a gap no other brand fills. But the multi-ingredient formula has not been tested outside Jinfiniti's own walls, and $118 per month buys hope, not proof. If the testing ecosystem appeals to you and budget is not a constraint, Jinfiniti offers something unique. If you want the most evidence per dollar, buy plain NMN from any reputable brand at a third of the price.

What We Did Not Review

We have not purchased the supplement, taken the NAD test, or independently validated the test's analytical methodology. This review covers the Vitality NAD+ Booster powder and lozenge from the brand's website and published materials, current through October 2026.

A full assessment would require taking the NAD test, using the supplement, retesting, and comparing the results with an independent NAD+ measurement. That is beyond the scope of a label-and-evidence review. Our best NMN supplements guide compares all brands, and our own product is on our NMN product page.

YourHealthier sells an NMN product. Jinfiniti did not commission, fund, or review this article.

Jinfiniti Vitality NAD+ Booster FAQ

Common questions about the product, pricing, and testing model.

What ingredients are in Jinfiniti Vitality NAD+ Booster?

NMN, creatine monohydrate, D-ribose, and niacinamide (vitamin B3). The product page lists no other ingredients.

How much does it cost?

$118 per jar one-time, $98 on subscription. The NAD+ test costs $198. Bundles range from $257 to $708.

Has the formula been tested in a published clinical trial?

No. Jinfiniti cites an internal 26-person study that has not been peer-reviewed or published. Each individual ingredient has published evidence, but the specific combination does not.

Who founded Jinfiniti?

Dr. Jin-Xiong She, PhD, a Professor Emeritus at Augusta University's Center for Biotechnology and Genomic Medicine. He has published over 400 scientific papers.

What is the intracellular NAD+ test?

A proprietary blood test that measures NAD+ levels inside cells rather than in blood plasma. Jinfiniti says it is the first commercially available test of its kind.

Is Jinfiniti's Vitality Booster worth the price?

That depends on how much you value the testing ecosystem and multi-ingredient approach. The NMN itself can be obtained from other brands for $17 to $69 per month. The testing is genuinely unique.

Does niacinamide actually raise NAD+?

A 2026 trial found that nicotinamide (niacinamide) did not raise blood NAD+ in a 14-day head-to-head against NMN and NR, which both did (Christen et al., 2026). Its role in the salvage pathway is established biochemistry, but the human supplementation result is worth noting.

Where can I compare other NMN products?

See our best NMN supplements guide, What Is NMN?, Omre review, and DoNotAge review.